share_log

Processa Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Guy Wendy

SEC announcement ·  Apr 13 04:53
Summary by Futu AI
On January 1, 2024, Wendy Guy, the Chief Administrative Officer of Processa Pharmaceuticals, Inc. (PCSA), completed a transaction involving the company's common stock. Guy executed a sale of 368 shares at a price of $2.79 per share, resulting in a total market value of $1,026.72. Following this transaction, Guy's direct holdings in Processa Pharmaceuticals decreased to 11,433 shares. Additionally, Guy holds an indirect interest in 8,335 shares through CorLyst, LLC. The transaction reflects a completed action as per the latest filing.
On January 1, 2024, Wendy Guy, the Chief Administrative Officer of Processa Pharmaceuticals, Inc. (PCSA), completed a transaction involving the company's common stock. Guy executed a sale of 368 shares at a price of $2.79 per share, resulting in a total market value of $1,026.72. Following this transaction, Guy's direct holdings in Processa Pharmaceuticals decreased to 11,433 shares. Additionally, Guy holds an indirect interest in 8,335 shares through CorLyst, LLC. The transaction reflects a completed action as per the latest filing.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.